Skip to search formSkip to main contentSkip to account menu

3-iodothyronamine

Known as: T(1)AM cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: 3-Iodothyronamine (3-T1AM) is an endogenous decarboxylated thyroid hormone (TH) metabolite. Pharmacological doses of… 
2017
2017
BACKGROUND Difficulties have been reported in quantitating 3-iodothyronamine (T1AM) in blood or serum, and tentatively attributed… 
2017
2017
Recent studies have further investigated the trace amine‐associated receptor type 2 (TAAR2) pharmacology, revealing its role not… 
2017
2017
Ovarian cancer is a highly aggressive disease and novel treatments are required. Thyroid hormones binding to αvβ3 integrin… 
2016
2016
Background: Critical illness is hallmarked by low circulating thyroxine (T4) and triiodothyronine (T3) concentrations, in the… 
2015
2015
Background: 3-Iodothyronamine (3-T<sub>1</sub>AM), a signaling molecule with structural similarities to thyroid hormones, induces… 
2014
2014
This study used an optical technique to measure the effects of treating low (10 mg/kg) and high (25 mg/kg) doses of 3… 
2009
2009
3‐iodothyronamine (T1AM) is a novel endogenous relative of thyroid hormone, able to interact with trace amine‐associated…